Bosnia and Herzegovina

ABSTRACT Two multicountry Global Fund grants in Eastern Europe and Central Asia, for TB and HIV, were approved in December 2018 by the Global Fund Board, for a total of $18 million. Implementation began on 1 January 2019, but there is lingering concern among applicants regarding the effectiveness of the competitive approach prescribed by the Global Fund for the application process. A member of one of the applicant organizations, the Eurasian Harm Reduction Association, reports on some applicants' concerns.

ABSTRACT This article, written by a team of Aidspan staff, gives insight into the situation in Bosnia and Herzegovina with regard to no longer having access to Global Fund money.

ABSTRACT The Secretariat is reviewing the impact of the new Policy on Sustainability, Transition, and Co-Financing on nine components no longer eligible for funding. In GFO #293, we reported that the Board decided not to fund proposed extensions to two grants in Bosnia and Herzegovina. This article provides more information on this decision.

ABSTRACT The Global Fund Board has declined to approve extensions for a TB and an HIV grant to Bosnia and Hercegovina. No reasons for the decision have been made public.

ABSTRACT Case studies conducted by the Eurasian Harm Reduction Network rate the readiness of four countries to transition harm reduction programs from Global Fund support to domestic funding at between 19% and 47%.

ABSTRACT Bosnia and Herzegovina will from December 2015 become ineligible for Global Fund financing, presenting a risk to a number of programs that the government has said it may be incapable of finding budgetary resources for. This could have an impact on currently low sero-prevalence rates nationwide, particularly within certain vulnerable populations such as the migrant Roma who live in poverty in informal settlements around the country.

ABSTRACT The Global Fund Board has approved Phase 2 funding for a Round 9 HIV grant in Bosnia and Hercegovina. Phase 2 will see a greater focus on high-impact interventions and most-at-risk populations, as well as on human rights activities.